Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 792 of 1,261

  1. US 8835639

    Process for making modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  2. US 8835491

    Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  3. US 8835513

    Drug delivery devices

    Covidien LP · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  4. US 8835556

    Hydrolytically stable maleimide-terminated polymers

    Nektar Therapeutics · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  5. US 8835599

    Segmented degradable polymers and conjugates made therefrom

    Nektar Therapeutics · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  6. US 8835630

    Acyclic nucleoside phosphonate diesters

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  7. US 8835510

    Methods and compositions for treating conditions mediated by oxidative stress or electrophilic environmental toxins

    Montefiore Medical Center · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  8. US 8835493

    Oligo-benzamide compounds for use in treating cancers

    The Board of Regents of the University of Texas System · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  9. US 8835430

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  10. US 8835505

    Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container

    Welgrace Research Group · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  11. US 8835420

    Azaindole derivatives

    Takeda Pharmaceutical Company Limited · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  12. US 8834883

    Anti-VEGF antibodies and uses thereof

    VACCINEX, INC. · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  13. US 8835166

    Extracellular matrix material created using non-thermal irreversible electroporation

    The Regents of the University of California · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  14. US 8835405

    Inhibiting arthritis via injection of synergistic combination of hyaluronic acid and vitamin C and/or vitamin E

    China Medical University · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  15. US 8834871

    Immunoglobulin molecules with improved characteristics

    The Board of Regents of the University of Texas System · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  16. US 8835613

    β-mannosylceramide and stimulation of NKT cell anti-tumor immunity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  17. US 8834854

    Oral treatment compositions and related methods of manufacture

    Ranir, LLC · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  18. US 8834921

    Sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  19. US 8834840

    Magnetic resonance imaging of self-assembled biomaterial scaffolds

    Northwestern University · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  20. US 8834938

    Use of arsenic for cancer therapy protection

    The Board of Regents of the University of Texas System · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  21. US 8834418

    Molds for in situ forming materials

    Covidien LP · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  22. US 8835378

    Multi-domain amphipathic helical peptides and methods of their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  23. US 8835380

    Therapeutic conjugates

    University College Cardiff Consultants Limited · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  24. US 8835167

    Humanized anti-tag 72 CC49 for diagnosis and therapy of human tumors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.